Mersana Therapeutics (0M4.F) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.18
-0.15
-0.12
-0.09

Details

Expected EPS
-0.16251690883999997
Actual EPS
-0.0851994
Surprise EPS
0.08
Surprise Percent
+47.58%

Description

Mersana Therapeutics (0M4.F) has reported earnings of -0.0851994 per share for Q4 2024.

0 Comments

Share your thoughts